2025.11.18
Graph's Cytodata 2026 poster: "Decoding the functional and molecular niche of immune-mediated disease for iterative target discovery"
Check out Graph's Cytodata 2026 poster at the link above
2025.10.07
Graph Therapeutics and Botnar Institute of Immune Engineering announce strategic collaboration to advance precision immunology
Collaboration combines Graph's AI-driven precision immunology platform with BIIE's immune engineering and modeling expertise to accelerate medicine development
2025.04.22
Graph Therapeutics awarded Deep Tech Life Science Seed Financing Grant from the Austrian Wirtschaftsservice worth €1.1M
Graph has recieved the deep tech life sciences seed program grant from the funding from the Austria Wirtschaftsservice (AWS) to advance our clinically realistic precision immunology platform.
2025.03.28
Graph co-founder Berend Snijder appointed as Faculty Professor at the Botnar Institute of Immune Engineering
The Snijder lab specializes in systems oncology and immunology research. His group at the BIIE will continue to bridge biology with machine learning methods to further our understanding of molecular systems for medicine.
2025.01.09
Graph Therapeutics Raises $3.1M Pre-Seed Round to Transform Drug Discovery for Immunological Diseases
Veteran techbio team that pioneered AI-driven precision oncology reunites to tackle the critical and complex challenges of inflammatory and immunological diseases
